1.650
1.65 (0%)
As of Dec 20, 2024
Pds Biotechnology Corp [PDSB]
Source:
Company Overview
Pds Biotechnology Corp is a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer and infectious disease immunotherapies based on our proprietary Versamune , Versamune plus IL-12 and Infectimune™ T cell activating technology platforms.
Country | United States |
Headquarters | florham park, new jersey |
Phone Number | 800-208-3343 |
Industry | manufacturing |
CEO | Frank Bedu-Addo, Ph.D. |
Website | www.pdsbiotech.com |